ASH 2024 featured practice-changing studies in lymphoid malignancies, including tafasitamab’s impact in FL, ibrutinib’s OS benefit in MCL, and promising epcoritamab data in CLL.

Novartis' CAR-T Kymriah has become the first therapy in the category to be approved for the treatment of relapsed/refractory follicular lymphoma, ahead of Gilead Sciences' rival Yescarta.

Click on "Filters". Select "Any condition" and choose "Cutaneous lymphoma." Because the first noticeable signs often appear on the skin, many people see a dermatologist to find out what’s causing ...

However, itchy skin can also be a sign of cancers that affect the genitals, specific forms of breast cancer, and other cancer types. The two blood-related cancers most likely to cause itching are ...

Members of the Leukemia and Lymphoma Society discussed the importance of educating others, fundraising and spreading ...

The diagnosis of spinal cord lymphoma is often delayed due to the high risks associated with a spinal cord biopsy, the rarity of the disease, and the lack of specificity of its clinicoradiological ...

This is the cold season, and many people are down with runny nose, fever, cough, and tiredness. However, according to experts ...

A guardian molecule ensures that liver cells do not lose their identity. This has been discovered by researchers from the ...

Topical ABT-263 effectively reduced several senescence markers in aged skin, preparing it for improved wound healing.

I tried the new AI scan for skin cancer with results in 30 seconds — and it's better than a dermatologist - The Skin ...

The following is a summary of “Frequency and timing of multiple skin cancer development in five cohorts,” published in the ...

A new pilot cohort study linked immune checkpoint inhibitors with a reduction in actinic keratoses in patients undergoing ...